[Diagnostic use of autoantibodies]

Area of Science:

• Autoantibody diagnostics in dermatology.
• Serodiagnosis in rheumatology and laboratory centers.

Context:

• Autoantibodies are relevant in bullous autoimmune diseases, connective tissue diseases, systemic vasculopathy, and psoriatic arthritis.
• Diagnosis of bullous skin diseases is targeted due to known autoantigen details.
• Pathogenetic roles of autoantibodies in connective tissue diseases are largely unknown.

Purpose:

• To highlight the importance of autoantibody diagnostics in various autoimmune and connective tissue diseases.
• To emphasize the diagnostic and monitoring utility of autoantibodies in clinical practice.
• To explore the potential future role of specific autoantibodies, like anti-cyclic citrullinated peptides, in psoriatic arthritis.

Summary:

• Autoantibody diagnostics are vital in dermatology for bullous autoimmune diseases, offering targeted insights into disease mechanisms and treatment response.
• While autoantibodies in connective tissue diseases are disease-specific, their pathogenic significance remains largely unclear.
• Autoantibody testing also plays a role in diagnosing certain vascular diseases and may evolve for psoriatic arthritis management.

Impact:

• Autoantibody profiles aid in initial diagnosis, disease course evaluation, and treatment success monitoring.
• Further research into autoantibodies in connective tissue diseases could reveal new diagnostic and therapeutic targets.
• The study underscores the expanding role of autoantibody diagnostics across multiple medical disciplines.